Public Management

Rwanda: Construction works for Africa’s first ARNm vaccine factory kicked-off

Rwanda: Construction works for Africa’s first ARNm vaccine factory kicked-off
Friday, 24 June 2022 21:33

In Africa, there is a growing number of initiatives to boost the local medicine production capabilities. In the same wake, leaders and international partners want to increase the number of vaccine factories on the continent. 

German pharmaceutical company BioNTech recently launched the construction of Africa's first modular messenger RNA (mRNA) vaccine manufacturing facility. It disclosed the event in a release published on its website last Thursday.  

Covering 30,000 square meters, the facility will initially be equipped with two BioNTainers, scheduled for completion by the end of 2022. It will employ nearly 100 people in the next two years.  

According to the release, the BioNTainers will specialize in the production  of "a range of mRNA-based vaccines targeted to the needs of the African Union member states, which could conceivably include the Pfizer-BioNTech COVID-19 vaccine and BioNTech's investigational malaria and tuberculosis vaccines, if they are successfully developed, approved or authorized by regulatory authorities.” They will produce approximately 50 million doses of Pfizer-BioNTech covid-19 vaccine per year and may also quick off the human stage of the malaria vaccine trial this year.  

"The company expects to set up additional factories in Senegal and South Africa in close coordination with its partners in the respective countries. The initial site will become a node in a decentralized and robust African end-to-end manufacturing network. All vaccines to be manufactured in the network will be dedicated to people residing in member states of the African Union," the release adds.

The German pharmaceutical company first announced an agreement with Rwanda and Senegal to build vaccine production plants last October 2021. It aims to create a continental network that will enable the production of millions of vaccines every year. 

This initiative comes at a time when African authorities are planning to strengthen the local production of pharmaceutical products. Currently, the continent manufactures about 1% of the vaccines it uses and the Africa Union wants to increase that percentage to 60% by 2040. 

Jean-Marc Gogbeu

Additional Info

  • communiques: Non
  • couleur: N/A
On the same topic
Côte d’Ivoire will receive $234 million for a sustainable urban mobility project in Abidjan. Gambia will receive $32.2 million to build...
Stanbic IBTC and Zenith Bank cut monthly card spending abroad to $500 and $200 Foreign reserves fall by $3.5 billion in six...
Cauri Money launches Gajo Money, an e-wallet for the Cameroonian diaspora, targeting €120 million in transactions by end-2025. The fintech...
• Kenya and ASR sign deal to reduce risk on projects worth up to $2 billion.• Risk cover will target infrastructure, energy, logistics, and trade...
Most Read
01

• Investors seem to keep focusing on yields, which are high for the moment• New Leadership might see...

Afreximbank Bonds Retain Market Confidence Despite Moody’s Downgrade
02

• Qatar Airways and Kenya Airways establish strategic agreement, introducing a third daily flight be...

Qatar Airways Expands its Network in Africa, Building Presence in Kigali, Johannesburg, and Nairobi
03

• ECOWAS Bank funds 47.7-km stretch of strategic 700-km road project• Lagos-Calabar highway seen boo...

Nigeria Secures $100 mln ECOWAS Bank Loan for Lagos-Calabar Coastal Highway
04

• EY is preparing to leave Francophone Sub-Saharan Africa by 2026• The exit could unlock $500 m...

EY’s Exit Creates $1bn Opportunity in Francophone Africa Consulting Market
05

• Inflation within the West African Economic and Monetary Union (UEMOA) fell to a two-year low of 0....

UEMOA: Inflation Drops to 0.6% in May, Driven by Lower Food Prices
Enter your email to receive our newsletter

Ecofin Agency provides daily coverage of nine key African economic sectors: public management, finance, telecoms, agribusiness, mining, energy, transport, communication, and education.
It also designs and manages specialized media, both online and print, for African institutions and publishers.

SALES & ADVERTISING

regie@agenceecofin.com 
Tél: +41 22 301 96 11 
Mob: +41 78 699 13 72
Média kit : Download

EDITORIAL
redaction@agenceecofin.com

More information
Team
Publisher

ECOFIN AGENCY

Mediamania Sarl
Rue du Léman, 6
1201 Geneva
Switzerland

 

Ecofin Agency is a sector-focused economic news agency, founded in December 2010. Its web platform was launched in June 2011. ©Mediamania.

 
 

Please publish modules in offcanvas position.